Cardiorenal syndrome - a new entity?

Ascites, Hyponatremia and Hepatorenal Syndrome: Progress in Treatment

Volumn 28, Issue , 2010, Pages 102-111

  Møller, Søren ^a   Krag, Aleksander ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84865798110     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000318984     Document Type: Chapter

References (30)

1. Gines P, Schrier RW: Renal failure in cirrhosis. N Engl J Med 2009;361:1279-1290.
2. Møller S, Henriksen JH: Cardiovascular complications of cirrhosis. Gut 2008;57:268-278.
3. Fernandez-Esparrach G, Sanchez-Fueyo A, Gines P, Uriz J, Quinto L, Ventura PJ, Cardenas A, Guevara M, Sort P, Jimenez W, Bataller R, Arroyo V, Rodes J: A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol 2001;34:46-52.
4. Wiest R, Garcia-Tsao G: Bacterial translocation (BT) in cirrhosis. Hepatology 2005;41:422-433.
5. Arroyo V, Terra C, Gines P: Advances in the pathogenesis and treatment of type- 1 and type- 2 hepatorenal syndrome. J Hepatol 2007;46:935-946.
6. Schrier RW: Decreased effective blood volume in edematous disorders: what does this mean? J Am Soc Nephrol 2007;18:2028-2031.
7. Ruiz-Del-Arbol L, Monescillo A, Arocena C, Valer P, Gines P, Moreira V, Maria MJ, Jimenez W, Arroyo V: Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology 2005;42:439-447.
8. Fasolato S, Angeli P, Dallagnese L, Maresio G, Zola E, Mazza E, Salinas F, Dona S, Fagiuoli S, Sticca A, Zanus G, Cillo U, Frasson I, Destro C, Gatta A: Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features. Hepatology 2007;45:223-229.
9. Salerno F, Gerbes A, Gines P, Wong F, Arroyo V: Diagnosis, prevention and treatment of the hepatorenal syndrome in cirrhosis: a consensus workshop of the international ascites club. Gut 2007;56:1310-1318.
10. Alqahtani SA, Fouad TR, Lee SS: Cirrhotic cardiomyopathy. Semin Liver Dis 2008;28:59-69.
11. Gerbes AL, Wernze H, Arendt RM, Riedel A, Sauerbruch T, Paumgartner G: Atrial natriuretic factor and renin- aldosterone in volume regulation of patients with cirrhosis. Hepatology 1989;9:417-422.
12. Lauer MS, Okin PM, Larson MG, Evans JC, Levy D: Impaired heart rate response to graded exercise: prognostic implications of chronotropic incompetence in the Framingham Heart Study. Circulation 1996;93:1520-1526.
13. Kumar A, Schupp E, Bunnell E, Ali A, Milcarek B, Parrillo JE: Cardiovascular response to dobutamine stress predicts outcome in severe sepsis and septic shock. Crit Care 2008;12:R35.
14. Ruiz-Del-Arbol L, Urman J, Fernandez J, Gonzalez M, Navasa M, Monescillo A, Albillos A, Jimenez W, Arroyo V: Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 2003;38: 1210-1218.
15. Krag A, Bendtsen F, Henriksen JH, Møller S: Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites. Gut 2010;59:105-110.
16. Sarraf M, Masoumi A, Schrier RW: Cardiorenal syndrome in acute decompensated heart failure. Clin J Am Soc Nephrol 2009;4:2013-2026.
17. Firth JD, Raine AEG, Ledingham JGG: Raised venous pressure: a direct cause of renal sodium retention in oedema. Lancet 1988;i:1033-1038.
18. Cirera I, Elizalde JI, Pique JM, Feu F, Casadevall M, Goldin E, Teres J, Bosch J, Rodes J: Anemia worsens hyperdynamic circulation of patients with cirrhosis and portal hypertension. Dig Dis Sci 1997;42:1697-1702.
19. Henriksen JH, Bendtsen F, Møller S: Normal red cell cardiac output in the hyperkinetic syndrome of alcoholic cirrhosis. J Hepatol 2001;34:782-783.
20. Tristani FE, Cohn JN: Systemic and renal hemodynamics in oliguric hepatic failure: effect of volume expansion. J Clin Invest 1967;46:1894-1906.
21. Ros J, Claria J, Jimenez W, Boschmarce M, Angeli P, Arroyo V, Rivera F, Rodes J: Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis. Hepatology 1995;22:915-920.
22. Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984;100:483-490.
23. Parrillo JE, Burch C, Shelhamer JH, Parker MM, Natanson C, Schuette W: A circulating myocardial depressant substance in humans with septic shock: septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest 1985;76:1539-1553.
24. Albillos A, de la HA, Gonzalez M, Moya JL, Calleja JL, Monserrat J, Ruiz-Del-Arbol L, Alvarez-Mon M: Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 2003;37:208-217.
25. Neubauer S: The failing heart-an engine out of fuel. N Engl J Med 2007;356:1140-1151.
26. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R: Cardiorenal syndrome. J Am Coll Cardiol 2008;52:1527-1539.
27. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW: Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 2004;109:1004-1009.
28. Rabie RN, Cazzaniga M, Salerno F, Wong F: The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt. Am J Gastroenterol 2009.
29. Stanley AJ, Forrest EH, Dabos K, Bouchier IAD, Hayes PC: Natriuretic effect of an adenosine- 1 receptor antagonist in cirrhotic patients with ascites. Gastroenterology 1998;115:406-411.
30. Brinch K, Møller S, Bendtsen F, Becker U, Henriksen JH: Plasma volume expansion by albumin in cirrhosis: relation to blood volume distribution, arterial compliance and severity of disease. J Hepatol 2003;39:24-31.